Sustained fracture risk reduction over 5 years with risedronate therapy

N B Watts; J Brown; D Hosking; S Adami; H Mulder; Jean-Yves Reginster; C Kasibhatla; A Chines

Back

$Sustained fracture risk reduction over 5 years with risedronate therapy$

Conference proceeding

Peer reviewed

Sustained fracture risk reduction over 5 years with risedronate therapy

N B Watts, J Brown, D Hosking, S Adami, H Mulder, Jean-Yves Reginster, C Kasibhatla and A Chines

Journal of Bone and Mineral Research, 16 (S1), 217 (2001); 23rd Annual Meeting of the ASBMR, Phoenix, Arizona, United States [US], Du 12 au 16 octobre 2001

2001

Abstract

General & internal medicine

Human health sciences

Médecine générale & interne

Sciences de la santé humaine

Metrics

1 Record Views

Details

Title: Sustained fracture risk reduction over 5 years with risedronate therapy
Creators - without role: N B Watts
J Brown
D Hosking
S Adami
H Mulder
Jean-Yves Reginster
C Kasibhatla
A Chines
Conference: Journal of Bone and Mineral Research, 16 (S1), 217 (2001); 23rd Annual Meeting of the ASBMR, Phoenix, Arizona, United States [US], Du 12 au 16 octobre 2001
Publisher: American Society for Bone and Mineral Research
Identifiers: 9952680808331
Academic Unit: King Saud University
Language: English
Resource Type: Conference proceeding